The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms

Annals of Neurology
A H Ropper, D C Poskanzer

Abstract

Fifty-two patients with acute and subacute transverse myelopathy (TM) were evaluated at the Massachusetts General Hospital between 1955 and 1975 and followed for 1 to 23 years (average, 5). Nineteen had symptoms of a recent acute infectious illness, 3 had cancer, and 1 had undergone a recent operation. There were four types of initial symptom. Twenty-four patients had paresthesias at the onset of the illness, 18 had pain, usually interscapular, 7 had leg weakness, and 3 had urine retention. Prognosis depended on the nature of the onset of TM. An acute catastrophic onset was generally associated with back pain and led to a poor outcome in 7 and a good outcome in only 1 of 11 patients. A subacute progressive onset over several days to four weeks, generally with ascending paresthesias or leg weakness, was associated with a good outcome in 15 and fair outcome in 17 of 37 patients. Preceding febrile illness, treatment with corticosteroids, and the nature of CSF abnormalities had no effect on outcome. Multiple sclerosis evolved in 7 patients during the follow-up period. Because of the frequency with which mass lesions were missed, the need for myelography in the diagnosis of TM is emphasized. The distinguishing clinical characteristi...Continue Reading

References

Nov 1, 1973·Archives of Neurology·E L Hogan, M R Krigman
Apr 1, 1973·Archives of Neurology·H L Lipton, R D Teasdall
May 1, 1968·American Journal of Public Health and the Nation's Health·A AntonovskyM Alter
Sep 1, 1955·Brain : a Journal of Neurology·H L HOFFMAN
Aug 1, 1963·Archives of Neurology·P H ALTROCCHI
Dec 7, 1963·Lancet·E J BELL, S J RUSSELL
Jan 1, 1964·Annals of Internal Medicine·G PRUSSIN, G KATABI
Dec 1, 1964·Brain : a Journal of Neurology·E L MANCALL, R K ROSALES
Sep 1, 1961·Brain : a Journal of Neurology·C A PALLISR L MORGAN
Jan 1, 1952·Neurology·A T STEEGMANN
May 1, 1952·The American Journal of Medicine·R D ADAMS, C S KUBIK

❮ Previous
Next ❯

Citations

Jan 1, 1993·Neuroradiology·S HoltåsK Fredriksson
Jan 1, 1994·Journal of Neuro-oncology·R GrantH S Greenberg
Nov 30, 2000·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·D N LucasD P Dob
Apr 23, 2004·Current Neurology and Neuroscience Reports·Thomas N Byrne
Apr 26, 2006·Current Neurology and Neuroscience Reports·Chitra KrishnanSanjay C Keswani
Jul 1, 1992·Journal of the Neurological Sciences·T FukazawaK Hamada
Dec 1, 1995·Journal of the Neurological Sciences·S M Baig, M A Khan
Mar 1, 1990·Pediatric Neurology·W H LinssenJ J Rotteveel
Jan 7, 2004·Journal of the Neurological Sciences·Michael HarzheimStephan Schmidt
Jan 8, 1999·Journal of the Neurological Sciences·S PradhanM K Kathuria
Jan 1, 1981·Paraplegia·E BoltshauserH Friderich
Jan 6, 2005·The Neurologist·Adam I KaplinDouglas A Kerr
Mar 4, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J SellnerH P Mattle
Aug 8, 1998·Acta Neurologica Scandinavica·J KalitaS K Mandal
Feb 1, 1992·Acta Paediatrica·M NussinovitchI Varsano
Feb 1, 1997·Archives of Disease in Childhood·G SébireM Tardieu
Oct 5, 2013·BMC Neurology·Alvaro Cobo CalvoSergio Martínez-Yélamos
Nov 16, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Colin WhiteAmeen Patel
Aug 1, 1996·Spinal Cord·R SakakibaraT Yamanishi
Sep 29, 2011·Journal of Neuroimmunology·Joerg-Patrick Stübgen
May 31, 2011·Autoimmunity Reviews·Andrea T Borchers, M Eric Gershwin
Jan 22, 2010·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Christian G E L De GoedeMichael G Pike
Apr 25, 2009·Autoimmunity Reviews·Maria José Sá
Jan 13, 2009·Pediatric Neurology·Wen-Chin WengWang-Tso Lee
Feb 3, 2006·Annals of Neurology·Brian G WeinshenkerVanda A Lennon
Apr 1, 1993·Cancer Treatment Reviews·W Boogerd, J J van der Sande
Mar 1, 1992·The Journal of Emergency Medicine·R D Schmidt, V Markovchick
Jan 1, 1984·Annals of the New York Academy of Sciences·C M Poser
Mar 1, 1994·The Journal of Infection·R SalonenM K Viljanen
Aug 30, 2005·Annals of Emergency Medicine·Heather S HammerstedtSeric Cusick
Mar 31, 2015·Clinical and Experimental Emergency Medicine·Yo HuhSang-Cheon Choi
Oct 12, 2013·Pediatric Neurology·Long ChenLi Jiang
Dec 23, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C A FuxS Zimmerli
Apr 22, 1999·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R BakshiW R Kinkel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.